author-photo

Eriko Sato

Juntendo University

28

Papers

242

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.

2020 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (3)
Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase

2018 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score

2018 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (7)
Comparison of the Clinical Outcomes of Nilotinib and Dasatinib Therapies in Newly Diagnosed Patients in the Chronic Phase of Chronic Myeloid Leukemia: A Retrospective Analysis

2018 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Comparison of the Clinical Outcomes of Nilotinib and Dasatinib Therapies in Newly Diagnosed Patients in the Chronic Phase of Chronic Myeloid Leukemia: A Retrospective Analysis

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors

2018 Medical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group

2017 Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Clinical Entity and Outcomes of Therapy-Related Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: Surveillance By the Chronic Myeloid Leukemia Cooperative Study Group

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.

2015 International Journal of Clinical and Experimental Pathology
Show All
- Source
- Cite
- Save
Citations (2)